The study, titled “Parent-Reported Household Tobacco and E-cigarette Exposure and Asthma Control in Children: A Cross-Sectional Study,” drew on electronic health record data from a large, diverse urban pediatric primary care network affiliated with Children’s Hospital of Philadelphia. The research team examined encounters recorded between July 2023 and March 2026, a 33-month window in which parents of children aged one year or older with an asthma diagnosis completed two standardized instruments: a parent tobacco treatment platform that asked who in the family used combustible tobacco or e-cigarettes, and an asthma control tool that assessed symptoms, medication use, and healthcare utilization. By pairing these two data sources across tens of thousands of visits, the investigators were able to examine how different patterns of household nicotine use tracked with day-to-day asthma outcomes as reported by the people who know the children best.

The scale of the dataset is one of its distinguishing strengths. Among 48,118 eligible encounters, 48 percent involved children aged six to twelve years, 42 percent were female, 34 percent were Non-Hispanic Black, 43 percent were covered by Medicaid, and 30 percent came from neighborhoods rated as having very low opportunity by the Child Opportunity Index. Household use of both tobacco and e-cigarettes was reported in 5 percent of visits, or 2,500 encounters; tobacco-only use in 9 percent, or 4,238 encounters; and e-cigarette-only use in 3 percent, or 1,427 encounters. This diversity matters, because asthma burden and tobacco exposure are not evenly distributed across pediatric populations, and the study’s statistical adjustments were designed to account for exactly these sociodemographic differences.

To isolate the effect of household exposure from other factors that influence asthma control, the researchers used multivariable logistic regression, estimating adjusted odds ratios with 95 percent confidence intervals while controlling for child age, sex, insurance status, and the Child Opportunity Index of the child’s neighborhood. The Children’s Hospital of Philadelphia institutional review board deemed the study exempt under the Common Rule. The statistical approach allowed the team to ask a deceptively simple question: after accounting for a family’s circumstances, does the presence of tobacco or e-cigarette use in the home still predict poorer asthma control? The answer, across multiple outcome domains, was yes.

Children exposed to both combustible tobacco and e-cigarettes in the home showed the broadest and strongest associations with poor asthma outcomes. Combined exposure was linked to more activity-related symptoms, with an adjusted odds ratio of 1.3; more nighttime symptoms, also 1.3; greater albuterol or rescue inhaler use, at 1.2; worse parent ratings of asthma control, at 1.3; lower parental comfort with asthma management, at 1.3; and hospital admissions in the past year, at 1.2. Children with combined exposure were also more likely to have poorly controlled asthma status, at 1.1, and were substantially more likely to have uncontrolled asthma, with an adjusted odds ratio of 1.4. In practical terms, this means more flares, more disrupted sleep, more missed activity, and more hospital stays for the children breathing air shared with the heaviest household nicotine users.

The most striking result, however, concerned e-cigarettes alone. E-cigarette-only exposure was independently associated with more asthma flares, with an adjusted odds ratio of 1.3, and more activity-related symptoms, at 1.4 — figures comparable to or exceeding those seen with combined tobacco and e-cigarette exposure. Tobacco-only exposure showed more modest but still significant associations across multiple domains. Not every measure moved in the same way: parent-reported emergency department or urgent care utilization and oral steroid use were not significantly associated with any exposure type after adjustment. But the pattern across flares, symptoms, and hospitalizations paints a consistent picture that vapor is not benign for asthmatic airways.

“There is no safe level of tobacco or e-cigarette exposure when it comes to children. Parents and caregivers who use any tobacco or nicotine products should make every effort to quit, using evidence-based options like varenicline, nicotine replacement therapy, and counseling,” said Brian Jenssen, MD, MSHP, FAAP, associate professor of pediatrics at Children’s Hospital of Philadelphia and the study’s principal investigator. His message to families is blunt: the long-promoted idea that vaping indoors is a harm-reduction strategy for households with children does not survive contact with the data on pediatric asthma.

“Many parents believe e-cigarettes are a safer alternative to cigarettes, both for themselves and for their children’s health. Our findings suggest that assumption doesn’t fully hold up for kids with asthma,” Jenssen said. He also framed the results as a call to action for clinicians: “It reinforces the need for pediatric care teams to screen for all forms of household nicotine and tobacco use — not just cigarettes — and to offer cessation support for both, as part of routine asthma care.” In other words, the clinic visit for an asthma flare may itself be the most teachable moment to ask not only whether anyone in the home smokes cigarettes, but whether anyone vapes — and to have cessation resources ready for either answer.

The biological plausibility behind these associations is well established in the broader literature. Secondhand smoke worsens respiratory illnesses in children, and asthma is particularly sensitive to inhaled irritants, which provoke airway inflammation, mucus production, and bronchial hyperreactivity. E-cigarette aerosols contain nicotine, ultrafine particles, flavoring compounds, and thermal degradation products, several of which are known to irritate or damage respiratory epithelium. What has been lacking until now is large-scale, real-world evidence on how e-cigarette exposure alone affects asthma control in children — a gap this study helps fill by showing that vapor-only households still carry measurable risk for the asthmatic children living in them.

The authors are careful to note the study’s design: it is cross-sectional, capturing exposure and outcomes at the same point in time, so it demonstrates associations rather than proving causation, and it relies on parent-reported exposure and asthma control rather than objective biomarkers or clinical measures. Still, the sheer number of encounters, the diversity of the population, and the consistency of the adjusted associations across symptom, medication, and hospitalization domains give the findings considerable weight. The work was funded by the National Institutes of Health under grant R37-CA282153, with Jenssen as principal investigator. Jenssen is scheduled to present the research at 3:40 p.m. PT on Saturday, October 3, at the Marriott Marquis, for the conference’s Section on Nicotine and Tobacco Prevention and Treatment, and will participate in a press Soundbite Session on Sunday, October 4. For the estimated six million American children with asthma — and the many households where a parent vapes believing it protects their kids — the study’s core conclusion lands with force: when a child’s lungs are already inflamed, the air they breathe at home matters, whatever form the nicotine takes.

Subject of Research: Household tobacco and e-cigarette exposure and asthma control in children

Article Title: E-cigarettes, tobacco in-home exposure linked to children’s asthma flare-ups

Article References: E-cigarettes, tobacco in-home exposure linked to children’s asthma flare-ups. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: e-cigarettes, secondhand smoke, pediatric asthma, asthma control, tobacco exposure, nicotine, Children's Hospital of Philadelphia, American Academy of Pediatrics, public health, smoking cessation, respiratory health, cross-sectional study